Oncology and Hematology
Episodes 113-128 of 307
- MinuteCE®
Panel Discussion: Patient Selection, Emerging Studies and Strategies in ES-SCLC
1.50 program creditsTiciana Leal, MD
Jacob Sands, MD
Paul Paik, MD
D. Ross Camidge, MD, PhD
Keith Kerr, BSc, MB ChB
Alicia K. Morgans, MD, MPH
Kelvin A. Moses, MD, PhD, FACS
Alicia K. Morgans, MD, MPH
Kelvin A. Moses, MD, PhD, FACS
Alicia K. Morgans, MD, MPH
Kelvin A. Moses, MD, PhD, FACS
Alicia K. Morgans, MD, MPH
Kelvin A. Moses, MD, PhD, FACS
- MinuteCE®
Intensifying ADT in mHSPC: How to Improve Patient Outcomes and Adherence
1.00 credit 8 episodesLisa Holle, PharmD, BCOP, FHOPA, FISOPP
Alicia K. Morgans, MD, MPH
Kelvin A. Moses, MD, PhD, FACS
Stacy Walker, NP
- MinuteCE®
Expert Panel: Selecting Treatment in mHSPC: Which Treatment for Which Patient?
1.00 program creditKelvin A. Moses, MD, PhD, FACS
Alicia K. Morgans, MD, MPH
- MinuteCE®
What Is the Pharmacist’s Role in Managing mHSPC Doublet and Triplet Regimens?
1.00 program creditLisa Holle, PharmD, BCOP, FHOPA, FISOPP
Charu Aggarwal, MD, MPH
Patrick Forde, M.B.B.Ch.
Charu Aggarwal, MD, MPH
Patrick Forde, M.B.B.Ch.
Charu Aggarwal, MD, MPH
Patrick Forde, M.B.B.Ch.
Charu Aggarwal, MD, MPH
Patrick Forde, M.B.B.Ch.
Charu Aggarwal, MD, MPH
Patrick Forde, M.B.B.Ch.